Test Price
2,800 AED✅ Home Collection Available
BSND Gene (Bartter Syndrome Type 4A) Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين BSND (متلازمة بارتر نوع 4A) بتقنية التسلسل من الجيل التالي في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
ملخص تنفيذي
الفحص الجيني لجين BSND يحدد الطفرات المسببة لمتلازمة بارتر من النوع 4A بحساسية تشخيصية فائقة تبلغ 99.9% عبر مختبر حاصل على شهادة الأيزو، مع خدمة سحب عينات منزلية متميزة.
-
✓
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
-
✓
Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy.
-
✓
Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
-
✓
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Overview
The BSND Gene NGS test screens for pathogenic variants causing Bartter Syndrome Type 4A, a rare autosomal recessive tubulopathy characterized by salt-wasting, hypokalemia, metabolic alkalosis, and sensorineural deafness. في الإمارات، يُجري هذا الفحص المتقدم تسلسلًا كاملاً لجين BSND لتأكيد التشخيص وتحديد الحالة الحاملة وراثياً واتخاذ القرارات الإنجابية.
| Feature | Our Test (BSND NGS) | Closest Alternative (Targeted Genotyping/WES) |
|---|---|---|
| Precision | >99% analytic sensitivity and specificity for BSND variants | May miss novel or deep intronic variants; lower resolution |
| Method | High-depth Next-Generation Sequencing (NGS) with full BSND exon and splice site coverage | Sanger sequencing of limited hotspots or exome-wide with insufficient BSND coverage |
| Speed | 3 to 4 Weeks | 6–8 Weeks (exome) or 2–3 Weeks (limited panel) |
Physician Insight & Safety Protocol
As a clinician, I understand the anxiety surrounding a possible genetic diagnosis. This test provides crucial clarity for families, but results must be correlated with clinical presentation and electrolyte panels. Remember, a gene mutation alone does not define your health outcome.
— Dr. PRABHAKAR REDDY (DHA License: 61713011)
Medication Warning: Do not discontinue prescribed medications without consulting your doctor. Abnormal electrolyte levels require immediate medical oversight.
⚠ Exclusion Criteria & Emergency Red Flags
- Minors without documented parental/guardian consent (UAE CDS Law 2026, Art. 15).
- Severe coagulation disorder (e.g., hemophilia) if blood sample required.
- Incomplete pre-test genetic counselling session or missing pedigree chart.
- Acute kidney injury, severe dehydration, or active cardiac arrhythmia – seek emergency care before sample collection.
Patient FAQ & Clinical Guidance
What is the BSND gene test and who should consider it?
The BSND NGS test identifies mutations in the gene responsible for Bartter Syndrome Type 4A, aiding diagnosis in individuals with unexplained hypokalemia, metabolic alkalosis, and sensorineural hearing loss. This test is recommended for children or adults presenting with salt-wasting, polyuria, and failure to thrive, especially when accompanied by early-onset deafness. Family members of a confirmed carrier can also benefit from cascade testing to assess reproductive risk.
ما هي متلازمة بارتر من النوع 4A وما أهمية فحص جين BSND؟
متلازمة بارتر من النوع 4A اضطراب وراثي نادر يؤثر على الكلى والسمع؛ فحص جين BSND يحدد الطفرة المسببة بدقة تشخيصية عالية. تنتج هذه المتلازمة عن طفرات في جين BSND مما يؤدي إلى خلل في نقل الكهارل عبر الأنابيب الكلوية وفقدان السمع الحسي العصبي. التشخيص الجيني المبكر يمكّن الأطباء من وضع خطة علاجية تحافظ على توازن الشوارد وتمنع المضاعفات الكلوية.
How do I prepare for the and what is the sample collection process?
A prior genetic counselling session to document a three-generation pedigree is mandatory, after which a blood sample, extracted DNA, or a single blood drop on FTA card can be collected at our home service. Our DHA-licensed phlebotomist arrives at your location between 8 AM and 11 PM, ensuring cold-chain transport to the laboratory. If you cannot produce a fresh blood sample, previously extracted DNA may be submitted under strict chain-of-custody protocols.
This examination is conducted in compliance with UAE Federal Decree-Law No. 41 of 2024 (Art. 87) and the CDS Law 2026 regarding minor consent. Your genetic and health information is processed under UAE PDPL (Personal Data Protection Law). Laboratory operations maintain ISO 9001:2015 certification (Cert: INT/EGQ/2509DA/3139).
All clinical interpretations require correlation with patient history and are not a substitute for professional medical advice.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians